Skip to main content
Erschienen in: BMC Infectious Diseases 1/2012

Open Access 01.12.2012 | Research article

Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women

verfasst von: Jennifer E Balkus, Caroline Mitchell, Kathy Agnew, Congzhou Liu, Tina Fiedler, Susan E Cohn, Amneris Luque, Robert Coombs, David N Fredricks, Jane Hitti

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2012

Abstract

Background

The presence of hydrogen peroxide (H2O2) producing Lactobacillus in the vagina may play a role in controlling genital HIV-1 shedding. Sensitive molecular methods improve our ability to characterize the vaginal microbiota; however, they cannot characterize phenotype. We assessed the concordance of H2O2-producing Lactobacillus detected by culture with quantitative PCR (qPCR) detection of Lactobacillus species commonly assumed to be H2O2-producers.

Methods

Samples were collected as part of a prospective cohort study of HIV-1 seropositive US women. Cervicovaginal lavage specimens were tested for L. crispatus and L. jensenii using 16S rRNA gene qPCR assays. Vaginal swabs were cultured for Lactobacillus and tested for H2O2-production. We calculated a kappa statistic to assess concordance between culture and qPCR.

Results

Culture and qPCR results were available for 376 visits from 57 women. Lactobacilli were detected by culture at 308 (82%) visits, of which 233 of 308 (76%) produced H2O2. L. crispatus and/or L. jensenii were detected at 215 (57%) visits. Concordance between detection of L. crispatus and/or L. jensenii by qPCR and H2O2-producing Lactobacillus by culture was 75% (kappa = 0.45).

Conclusions

Among HIV-1 seropositive women, there was a moderate level of concordance between H2O2-producing Lactobacillus detected by culture and the presence of L. crispatus and/or L. jensenii by qPCR. However, one-quarter of samples with growth of H2O2-producing lactobacilli did not have L. crispatus or L. jensenii detected by qPCR. This discordance may be due to the presence of other H2O2-producing Lactobacillus species.
Hinweise

Competing interests

The authors declare no commercial or other associations that might pose a conflict of interest.

Authors’ contributions

JEB, CM, and JH conceived of the study and participated in its design. JB performed the statistical analysis and drafted the initial manuscript. KA performed the culture assays. CL and TF performed the species-specific qPCR and broad range bacterial PCR assays in the lab of DNF who oversaw the performance of the qPCR assays and participated in the design of the study. SEC, AL and RC participated in the design of the original cohort study and participated in the design of the present study. All authors read and approved the final manuscript.

Background

Bacterial vaginosis (BV) and BV-associated organisms have been associated with an increased risk of HIV-1 RNA genital tract shedding [1, 2]. Conversely, the presence of hydrogen peroxide (H2O2) producing lactobacilli in the vagina has been associated with a reduced likelihood of HIV-1 RNA shedding [2, 3]. Thus, it is hypothesized that H2O2-producing lactobacilli may play an important role in controlling genital HIV-1 shedding. The development of sensitive molecular methods, such as 16S rRNA gene polymerase chain reaction (PCR) assays, improves our ability to characterize the vaginal microbiota; however, they cannot characterize H2O2 production [4]. As cultivation-independent methods become more widely used, it is important to understand how these novel methods compare to traditional culture-based methods. Lactobacillus crispatus and L. jensenii are two of the most commonly detected species of vaginal lactobacilli and the majority of strains have been found to produce H2O2[5, 6]. We sought to assess the concordance of H2O2-producing Lactobacillus detected by culture with presumptive H2O2-producing Lactobacillus species detected by quantitative PCR (qPCR) among a cohort of HIV-seropositive women.

Methods

We used samples collected as part of a prospective cohort study of HIV-1 seropositive women conducted from 2002–2007 in Seattle, WA and Rochester, NY. The institutional review boards at the University of Washington and University of Rochester approved the study and participants provided written informed consent. At enrollment, eligible women were 18–50 years old, HIV-1 seropositive and not pregnant. Women were not eligible to enroll if they had active substance abuse that would preclude their ability to participate in the study or if they had a hysterectomy. Participants had 4 study visits in the first year and 3 visits per year in subsequent years. Each study visit included a face-to-face interview to ascertain information on demographics, sexual behavior, medication use, and reproductive and medical history. Plasma was obtained for HIV-1 RNA quantification. A pelvic examination was performed with collection of vaginal swabs for diagnosis of vaginal infections and Lactobacillus culture. Vaginal fluid specimens were not collected if the participant was menstruating. Bacterial vaginosis was diagnosed from vaginal Gram stain using Nugent’s criteria [7]. Trichomonas vaginalis was detected by culture using the InPouch system (Biomed Diagnostics, White City, Oregon). The presence and quantity of Lactobacillus was assessed by vaginal culture on Columbia 5% sheep blood and Rogosa agar. Isolates from blood agar were grown in 5-10% CO2. Isolates from Rogosa agar were incubated anaerobically. All colonies with morphology suggestive of Lactobacillus on blood agar as well as any colonies growing on Rogosa were isolated and identified on the basis of colony morphology and Gram stain [8, 9]. These isolates were subcultured on tetramethylbenzidine (TMB) agar containing horseradish peroxidase in order to assess hydrogen peroxide (H2O2) production [10, 11].
Cervicovaginal lavage (CVL) was collected by washing the ectocervix and vaginal walls with 7 mL of 10 mM lithium chloride solution, which was then collected from the vaginal pool, spun at 800 g for 5 minutes to separate the epithelial cells and stored at −80°C. Plasma and CVL HIV-1 RNA were quantified by an independently validated real-time PCR assay described previously [12], with a lower limit of detection of 30 copies/mL.
The frozen cell pellet from CVL was thawed and underwent DNA extraction with the MO BIO Bacteremia Isolation Kit (MO BIO Laboratories, Inc., Carlsbad, CA). Extracted DNA was tested by quantitative PCR using primers targeting the human 18S rRNA gene to validate that successful DNA extraction occurred and an internal amplification control PCR using exogenous DNA from a jellyfish gene was used to test for presence of PCR inhibitors [13]. Samples were then subjected to taxon-directed 16S rRNA gene qPCR assays for the detection and quantification of L. crispatus and L. jensenii. Each assay had been validated previously and proven to be sensitive (to a level of 1–10 DNA copies/reaction) and specific (does not detect other bacteria at a concentration of 106 copies/reaction) [14, 15]. The assays used a TaqMan format and were run on an ABI 7500 Thermocycler (Applied Biosystems, Foster City, CA) or Eppendorf Mastercycler ep Realplex thermal cycler (Eppendorf, Westbury, NY). Negative assays were assigned a value at the lower limit of detection for that assay.
Based on the findings from our analysis of concordance, we conducted an exploratory analysis using broad range 16S rRNA gene PCR on a subset of culture isolates derived from samples with high quantities of H2O2-producing Lactobacillus by culture (≥ 106 colony forming units [CFUs]), but with negative results for both L. crispatus and L. jensenii by qPCR in CVL. Lactobacillus isolates were retrieved from −80°C storage and streaked to Rogosa agar and Columbia agar with 5% sheep blood. A repeat streak to fresh agar was performed in order to obtain new isolates for broad range PCR testing. Genomic DNA was extracted from single bacterial colonies, single colonies converted to a lawn of bacteria (patches), or streaks of colonies on plates using the BiOstic Bacteremia DNA Isolation kit (MO BIO Laboratories, Inc., Carlsbad, CA). PCR was performed to amplify a portion of the bacterial 16S rRNA gene using combinations of the following broad range bacterial primers: 27 F bact (5'-AGAGTTTGATCMTGGCTCAG-3'), 338 F (5'-ACTCCTRCGGGAGGCAGCAG-3'), 806R (5'-GGACTACCAGGGTATCTAAT-3') and 1407R (5'-GACGGGCGGTGWGTRCA-3'). A range of 10ul neat DNA to 1ul 1:10 diluted DNA was added to 50ul reaction. Thermal cycling consisted of pre-melting at 95°C for 2 minutes, followed by 25 cycles of melting at 95°C for 30 seconds, annealing at 55°C or 60°C for 30 seconds and extension at 72°C for 2 minutes, with a final extension at 72°C for 10 minutes. PCR products were cleaned using the 0.5-mL 100 K Amicon Ultra Centrifugal Filters (Millipore, Billerica, MA). The same PCR primers were used in the sequencing reactions using ABI Prism 3730xI DNA Analyzer and BigDye chemistry. Sequencher software (GeneCodes, Ann Arbor, MI) was used to assemble sequence data. Sequences of the isolates (~800 base pairs in length) were compared to known bacterial sequences in Genbank by BLAST algorithm. Identities of the isolates to known species was defined by having >98% sequence similarity.
We used descriptive statistics for planned and exploratory analyses and calculated a kappa statistic to assess concordance between culture and qPCR using Stata version 11.0 (StataCorp, College Station, TX).

Results

Culture and qPCR results were available for 376 visits from 57 women. The median number of visits per woman was 6 (interquartile range (IQR): 3–6; range: 1–15). The median age of participants at enrollment was 38 (IQR: 35–42) and 33 (58%) reported African-American race. The median CD4 count and plasma viral load was 417 cells/mm3 (IQR: 254–639) and 370 copies/mL (IQR: <30 – 15, 850), respectively. Over half of women were on antiretroviral therapy at enrollment and BV by Gram stain was present among 24 (42%) women.
Lactobacilli were detected by culture at 308 (82%) visits, of which 233 of 308 (76%) produced H2O2 . The median quantity of H2O2+ Lactobacillus was 1.0E + 107 CFUs (IQR: 4.0E + 105, 2.0E + 108) among visits where Lactobacillus was detected by culture. L. crispatus was detected by qPCR at 173 (46%) visits. Among visits with detectable L. crispatus, the median quantity was 5.6E + 106 gene copies per sample (IQR: 7.0E + 104, 4.1E + 107). L. jensenii was detected slightly less often at 130 (35%) of visits. Among visits with detectable L. jensenii, the median quantity was 10.7E + 105 gene copies per sample (IQR: 2.2E + 105, 7.1 + 106). L. crispatus alone was detected at 85 (23%) visits and L. jensenii alone was detected at 42 (11%) visits. Both bacteria were present at 88 (23%) visits and either L. crispatus and/or L. jensenii were present at 215 (57%) visits. Concordance between detection of L. crispatus and/or L. jensenii by qPCR and H2O2-production by culture was 75% (kappa = 0.45), which equates to a modest level of agreement (Table 1).
Table 1
Lactobacillus species detected by qPCR compared to H 2 O 2 + Lactobacillus detected by culture*
Species Detected by PCR
H2O2+LactobacillusDetected by Culture
Detected n = 233
Not detected n = 143
 
N (%)
N (%)
L. crispatus
Detected
149 (64)
24 (17)
Not detected
84 (36)
119 (83)
L. jensenii
Detected
107 (46)
23 (16)
Not detected
126 (54)
120 (84)
L. crispatus and/or L. jensenii
Detected
174 (75)
41 (29)
 
Not detected
59 (25)
102 (71)
*N = 376 samples.
Given the moderate level of agreement between culture and qPCR, we conducted an exploratory analysis using broad range PCR on a subset of culture samples that had high quantities of H2O2-producing Lactobacillus by culture, but were negative for both L. crispatus and L. jensenii in CVL by qPCR. Twenty-five samples from 13 different women met our inclusion criteria for the exploratory analysis (8 women had one sample, 4 women had 2 samples and 1 woman had 9 samples). We selected 16 samples to undergo additional broad range PCR testing: one sample from each participant with ≤2 eligible samples (n = 12) and 4 from the participant with 9 eligible samples. For participants with 2 eligible samples, the sample with the highest quantity of Lactobacillus by culture was selected. If the quantity of Lactobacillus by culture was the same, the first visit in the series was selected. For the participant with 9 eligible samples, the 4 with the highest quantities of Lactobacillus by culture were selected. The prevalence of Lactobacillus species detected by broad range PCR is presented in Table 2. L. gasseri was the dominant species and was present among 81% of samples, including all isolates from the participant who contributed 4 samples.
Table 2
Prevalence of Lactobacillus species detected using broad range PCR among a subset of culture samples*
Species
Number of samples with species detected1n = 16
L. gasseri
13 (81)
L. crispatus
2 (13)
L. iners 2
2 (13)
L. johnsonii
2 (13)
L. coleohominis
1 (6)
L. oris
1 (6)
L. reuteri
1 (6)
L. rhamnosus
1 (6)
*Samples from women with high quantities of H2O2-producing Lactobacillus by culture (≥ 106 CFUs), but were negative for both L. crispatus and L. jensenii in CVL by qPCR.
1Percent total >100% since several isolates contained more than one species.
2H2O2-functionality was reassessed for the 2 isolates that were identified as L. iners. No H2O2-production was observed.

Discussion

Among HIV-1 seropositive women, 19% of samples with detectable L. crispatus or L. jensenii by qPCR were negative for H2O2-producing Lactobacillus by culture. It has been reported that 95% of L. crispatus isolates and 94% of L. jensenii isolates cultured from vaginal fluid were observed to be H2O2-producers [5]. The discordance observed in our initial analysis could be due to more frequent detection of H2O2-nonproducing strains of these species by qPCR, or the L. crispatus and L. jensenii strains that grow well in the laboratory may over-represent those that produce H2O2 compared to the original pool of bacteria. Conversely, a quarter of samples that were positive for H2O2-producing Lactobacillus by culture had undetectable quantities of L. crispatus and L. jensenii by qPCR. This finding may be due to the presence of other less prevalent Lactobacillus species such as L. gasseri, which is commonly an H2O2-producer [6]. This discordance prompted an exploratory analysis, which showed that L. gasseri was indeed the predominant species detected among women who had high quantities of H2O2-producing Lactobacillus by culture (≥ 106 CFUs), but were negative for both L. crispatus and L. jensenii in CVL by qPCR.
L. gasseri has been associated with the presence of abnormal vaginal microbiota [8], which may explain its detection in the absence of L. crispatus and L. jensenii, two species that are associated with a normal vaginal microbiota [4]. Though the proportion of L. gasseri isolates that are H2O2-producers is reported to be high (71-82%) [5, 6], the prevalence of L. gasseri in the vagina is relatively low compared to L. crispatus and L. jensenii[5, 16]. It is possible that L. gasseri is more prevalent in this population of HIV-1 infected women; however, since species-specific assays for L. gasseri were not performed and broad range PCR was conducted on only a subset of samples we do not know the overall prevalence of L. gasseri.
Our exploratory analysis also revealed a number of other Lactobacillus species besides L. crispatus, L. jensenii, and L. gasseri that appear capable of H2O2 production (Table 2). Among HIV-1 seropositive women, detection of H2O2-producing lactobacilli in the vagina has been associated with a reduced likelihood of genital HIV-1 shedding [2, 3]. In addition, several epidemiologic studies conducted among HIV-seronegative women have reported an association between the presence of H2O2-producing Lactobacillus and a decreased risk of genital tract infections, including HIV-1 [1720], leading to the hypothesis that H2O2 may inhibit genital tract pathogens. However, recent evidence indicates that in vivo concentrations of H2O2 produced from Lactobacillus may not be sufficient to provide protection against genital tract infections [21, 22]. Given the evidence from epidemiological studies, it is possible that H2O2 production may serve as a marker for other phenotypes that play a role in the suppression of HIV-1 genital shedding and protection against genital tract infections. Additional studies are needed to improve our understanding of the biological mechanisms that contribute to reductions in genital HIV shedding and protection against genital tract infections.
Until recently, our understanding of the bacterial species associated with BV was limited to those species that could be detected by culture. Molecular techniques that detect bacterial genes such as the 16S ribosomal RNA (rRNA) gene have been used to characterize the vaginal microbiota and have revealed several new species [4]. Broad range and species-specific quantitative PCR assays allow for detection of both cultivation-resistant and cultivatable bacterial species, thus providing a more comprehensive characterization of the vaginal microbiota. However, cultivation approaches continue to play an important role in the characterization of the vaginal microbiota, as they provide important phenotypic information. Compared to molecular methods, culture is inexpensive and requires less technical skill, time, and infrastructure to generate results. Information generated from the use of culture and molecular methods performed in combination will likely continue to generate useful information about how the vaginal microbiota impacts human health.
This analysis should be interpreted in the context of several limitations. Our analysis population consisted of HIV-1 seropositive women; therefore, our findings may not be generalizable to HIV-1 uninfected women. Since species level identification of Lactobacillus culture isolates was not performed, we can’t directly compare the species level concordance by culture and qPCR of CVL. We used species-specific qPCR assays that are highly sensitive and can detect species even at very low levels. However, we did not develop or apply assays for every known Lactobacilus species. Note that we did not attempt to correlate culture results with detection of L. iners since this bacterium is typically not an H2O2 producer [5, 16, 23].

Conclusions

The two most prevalent H2O2-producing Lactobacillus species that colonize the vagina, L. crispatus and/or L. jensenii, were detected among three-quarters of specimens that had detectable H2O2-producing Lactobacillus by culture. However, one-quarter of specimens with detectable H2O2-producing Lactobacillus by culture were negative for L. crisaptus and L. jensenii. This discordance lends support to the use of both culture and molecular methods to characterize the vaginal microbiota. Culture plays an important role in characterizing the vaginal microbiota by determining the metabolic capabilities of these bacteria, while the use of molecular methods enables the detection of cultivatable and cultivation resistant species. The use of these methodologies in combination holds great promise for improving our understanding of the vaginal microbiota and the molecular epidemiology of BV.

This abstract was presented at the Annual Scientific Meeting and Symposium of the Infectious Diseases Society for Obstetrics and Gynecology, in Santa Fe, NM; August 5–7, 2010

Acknowledgements

We gratefully acknowledge support from our clinic staff, laboratory staff and administrators for their dedication and hard work. We sincerely thank the women whose time, effort, and commitment made this research possible.
This research was supported by grants from the National Institutes of Health [grant R21 AI080439 and P01 HD040540]. JE Balkus was supported in part by a grant from the University of Washington Center for AIDS and STDs [grant T32 AI007140-32].
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare no commercial or other associations that might pose a conflict of interest.

Authors’ contributions

JEB, CM, and JH conceived of the study and participated in its design. JB performed the statistical analysis and drafted the initial manuscript. KA performed the culture assays. CL and TF performed the species-specific qPCR and broad range bacterial PCR assays in the lab of DNF who oversaw the performance of the qPCR assays and participated in the design of the study. SEC, AL and RC participated in the design of the original cohort study and participated in the design of the present study. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CCJ: Association between Bacterial Vaginosis and Expression of Human Immunodeficiency Virus Type 1 RNA in the Female Genital Tract. Clin Infect Dis. 2001, 33 (6): 894-896. 10.1086/322613.CrossRefPubMed Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CCJ: Association between Bacterial Vaginosis and Expression of Human Immunodeficiency Virus Type 1 RNA in the Female Genital Tract. Clin Infect Dis. 2001, 33 (6): 894-896. 10.1086/322613.CrossRefPubMed
2.
Zurück zum Zitat Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005, 191 (1): 25-32. 10.1086/426394.CrossRefPubMed Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005, 191 (1): 25-32. 10.1086/426394.CrossRefPubMed
3.
Zurück zum Zitat Hitti JE, Paul K, Agnew K, Gausman R, Lockhart D, Cohn S, Luque ARC: Protective Effect of Vaginal Lactobacillus on Genital HIV-1 RNA Concentrations: Longitudinal Data from a US Cohort Study (#27LB). Conference on Retrovirus and Opportunistic Infections. 2010, , San Francisco, CA, February 16–19 Hitti JE, Paul K, Agnew K, Gausman R, Lockhart D, Cohn S, Luque ARC: Protective Effect of Vaginal Lactobacillus on Genital HIV-1 RNA Concentrations: Longitudinal Data from a US Cohort Study (#27LB). Conference on Retrovirus and Opportunistic Infections. 2010, , San Francisco, CA, February 16–19
4.
Zurück zum Zitat Fredricks DN, Fiedler TL, Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005, 353 (18): 1899-1911. 10.1056/NEJMoa043802.CrossRefPubMed Fredricks DN, Fiedler TL, Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005, 353 (18): 1899-1911. 10.1056/NEJMoa043802.CrossRefPubMed
5.
Zurück zum Zitat Antonio MA, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis. 1999, 180 (6): 1950-1956. 10.1086/315109.CrossRefPubMed Antonio MA, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis. 1999, 180 (6): 1950-1956. 10.1086/315109.CrossRefPubMed
6.
Zurück zum Zitat Antonio M, Petrina M, Meyn L, Hillier S: Lactobacillus Crispatus Colonisation Reduces Risk of Bacterial Vaginosis (BV) Acquisition (Abtract # P3-S7.16). 2011, International Society for Sexually Transmitted Disease Research, Quebec City, Canada Antonio M, Petrina M, Meyn L, Hillier S: Lactobacillus Crispatus Colonisation Reduces Risk of Bacterial Vaginosis (BV) Acquisition (Abtract # P3-S7.16). 2011, International Society for Sexually Transmitted Disease Research, Quebec City, Canada
7.
Zurück zum Zitat Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991, 29 (2): 297-301.PubMedPubMedCentral Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991, 29 (2): 297-301.PubMedPubMedCentral
8.
Zurück zum Zitat Marrazzo JM, Antonio M, Agnew K, Hillier SL: Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis. 2009, 199 (5): 680-683. 10.1086/596632.CrossRefPubMedPubMedCentral Marrazzo JM, Antonio M, Agnew K, Hillier SL: Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis. 2009, 199 (5): 680-683. 10.1086/596632.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Moore LVH, Moore WEC, Cato EP, Virginia Polytechnic Institute and State University: Anaerobe laboratory manual. 1977, Anaerobe Laboratory, Blacksburg, Va, 4 Moore LVH, Moore WEC, Cato EP, Virginia Polytechnic Institute and State University: Anaerobe laboratory manual. 1977, Anaerobe Laboratory, Blacksburg, Va, 4
10.
Zurück zum Zitat Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, Holmes KK: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989, 27 (2): 251-256.PubMedPubMedCentral Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, Holmes KK: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989, 27 (2): 251-256.PubMedPubMedCentral
11.
Zurück zum Zitat Rabe LK, Hillier SL: Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol. 2003, 41 (7): 3260-3264. 10.1128/JCM.41.7.3260-3264.2003.CrossRefPubMedPubMedCentral Rabe LK, Hillier SL: Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol. 2003, 41 (7): 3260-3264. 10.1128/JCM.41.7.3260-3264.2003.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C: Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007, 196 (10): 1500-1508. 10.1086/522523.CrossRefPubMed Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C: Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007, 196 (10): 1500-1508. 10.1086/522523.CrossRefPubMed
13.
Zurück zum Zitat Khot PD, Ko DL, Hackman RC, Fredricks DN: Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008, 8: 73-10.1186/1471-2334-8-73.CrossRefPubMedPubMedCentral Khot PD, Ko DL, Hackman RC, Fredricks DN: Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008, 8: 73-10.1186/1471-2334-8-73.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM: Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR. J Clin Microbiol. 2009, 47 (3): 721-726. 10.1128/JCM.01384-08.CrossRefPubMedPubMedCentral Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM: Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR. J Clin Microbiol. 2009, 47 (3): 721-726. 10.1128/JCM.01384-08.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN: Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010, 5 (4): e10197-10.1371/journal.pone.0010197.CrossRefPubMedPubMedCentral Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN: Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010, 5 (4): e10197-10.1371/journal.pone.0010197.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Antonio MA, Rabe LK, Hillier SL: Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis. 2005, 192 (3): 394-398. 10.1086/430926.CrossRefPubMed Antonio MA, Rabe LK, Hillier SL: Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis. 2005, 192 (3): 394-398. 10.1086/430926.CrossRefPubMed
17.
Zurück zum Zitat Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Bwayo J, Kreiss J, Ndinya-Achola JO: Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition. J Infect Dis. 1999, 18 (6): 1863-1868.CrossRef Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Bwayo J, Kreiss J, Ndinya-Achola JO: Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition. J Infect Dis. 1999, 18 (6): 1863-1868.CrossRef
18.
Zurück zum Zitat Cherpes TL, Meyn LA, Krohn MA, Hillier SL: Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis. 2003, 30 (5): 405-410. 10.1097/00007435-200305000-00006.CrossRefPubMed Cherpes TL, Meyn LA, Krohn MA, Hillier SL: Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis. 2003, 30 (5): 405-410. 10.1097/00007435-200305000-00006.CrossRefPubMed
19.
Zurück zum Zitat Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL: Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003, 36 (5): 663-668. 10.1086/367658.CrossRefPubMed Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL: Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003, 36 (5): 663-668. 10.1086/367658.CrossRefPubMed
20.
Zurück zum Zitat Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996, 174 (5): 1058-1063. 10.1093/infdis/174.5.1058.CrossRefPubMed Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996, 174 (5): 1058-1063. 10.1093/infdis/174.5.1058.CrossRefPubMed
21.
Zurück zum Zitat O'Hanlon DE, Lanier BR, Moench TR, Cone RA: Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis. 2010, 10: 120-10.1186/1471-2334-10-120.CrossRefPubMedPubMedCentral O'Hanlon DE, Lanier BR, Moench TR, Cone RA: Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis. 2010, 10: 120-10.1186/1471-2334-10-120.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat O'Hanlon DE, Moench TR, Cone RA: In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis. 2011, 11: 200-10.1186/1471-2334-11-200.CrossRefPubMedPubMedCentral O'Hanlon DE, Moench TR, Cone RA: In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis. 2011, 11: 200-10.1186/1471-2334-11-200.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Falsen E, Pascual C, Sjoden B, Ohlen M, Collins MD: Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int J Syst Bacteriol. 1999, 49 Pt 1: 217-221.CrossRefPubMed Falsen E, Pascual C, Sjoden B, Ohlen M, Collins MD: Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int J Syst Bacteriol. 1999, 49 Pt 1: 217-221.CrossRefPubMed
Metadaten
Titel
Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women
verfasst von
Jennifer E Balkus
Caroline Mitchell
Kathy Agnew
Congzhou Liu
Tina Fiedler
Susan E Cohn
Amneris Luque
Robert Coombs
David N Fredricks
Jane Hitti
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2012
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-188

Weitere Artikel der Ausgabe 1/2012

BMC Infectious Diseases 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.